Collaboration Details

Title of Collaborative Activity:

Partnership for Tuberculosis (TB) and TB/HIV Research

Description of Collaborative Activity:

NIH/CDC partnership to develop methods and strategies to improve upon drug susceptibility testing methods for Pyrazinamide (PZA) and discovery of transcriptional markers of viable Mycobacterium tuberculosis (MTB) during treatment, markers of persistence, and markers of treatment response in active pulmonary Tuberculosis (TB).

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2012

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

CDC